Neutrally Charged Phosphorodiamidate Morpholino Antisense Oligomers: Uptake, Efficacy and Pharmacokinetics

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|5|5|431-439

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.5, Iss.5, 2004-10, pp. : 431-439

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cellular Uptake of Neutral Phosphorodiamidate Morpholino Oligomers

By  

Current Pharmaceutical Biotechnology, Vol. 10, Iss. 6, 2009-09 ,pp. : 579-588

Bentham Science Publishers

Access to resources Recommend Favorite

Antisense oligonucleotide pharmacokinetics and metabolism

By Geary Richard S  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 4, 2009-04 ,pp. : 381-391

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of RNA Virus Infections with Peptide-Conjugated Morpholino Oligomers

By  

Current Pharmaceutical Design, Vol. 14, Iss. 25, 2008-09 ,pp. : 2619-2634

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical pharmacokinetics of second generation antisense oligonucleotides

By Yu Rosie Z   Grundy John S   Geary Richard S  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 2, 2013-02 ,pp. : 169-182

Informa Healthcare

Access to resources Recommend Favorite

Personalised Genetic Intervention for Duchenne Muscular Dystrophy: Antisense Oligomers and Exon Skipping

By  

Current Molecular Pharmacology, Vol. 2, Iss. 1, 2009-01 ,pp. : 110-121

Bentham Science Publishers

Access to resources Recommend Favorite